Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Recruiting
Phase 1
Phase 2
Interventional Study
Parkinson Disease
Multiple System Atrophy
Progressive Supranuclear Palsy(PSP)
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 45 and older
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 15 (estimated)
- Sponsor
- Prabesh Kanel · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This research is studying a supplement called tributyrin in people with Progressive Supranuclear Palsy (PSP) to learn about its safety and tolerability as a potential treatment. The goal of this research study is to see if a similar supplementation regimen and virtual testing is feasible for people with PSP.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or Female, age 45 years and over.
* Diagnosis of PSP-Richardson syndrome (RS) based on Movement Disorder Society (MDS) Criteria, including
1. Vertical supranuclear gaze palsy.
2. Repeated unprovoked falls OR tendency to fall on the pull test within 3 years.
* Access …
Contacts